NGAGE Tool for Family Engagement
(NGAGE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new tool called NGAGE, designed to involve family members of ICU patients more in their loved one's care. The researchers aim to determine if NGAGE can improve family communication with healthcare teams and increase satisfaction with the care their loved ones receive. The trial also examines whether NGAGE can reduce stress, anxiety, and depression in family members. Participants must be adults related to someone in the ICU for at least 48 hours and able to speak English or French. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance family involvement in ICU care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the NGAGE tool is safe for family engagement in ICU settings?
Research shows that the NGAGE tool helps family members become more involved in patient care. Testing with families in other studies has shown that it increases their involvement in the care process. Importantly, no reports of harmful effects have emerged from using the NGAGE tool, suggesting it is safe for family members. While it enhances family engagement, it does not appear to cause any problems or risks for users.12345
Why are researchers excited about this trial?
Researchers are excited about the NGAGE tool because it offers a fresh approach to family engagement in healthcare settings. Unlike standard practices that rely on traditional methods of communication and involvement, the NGAGE tool aims to enhance family participation by providing structured and interactive support. This tool could lead to more effective collaboration between families and healthcare providers, potentially resulting in better health outcomes. By focusing on active engagement, NGAGE could transform how families contribute to and participate in the care process.
What evidence suggests that the NGAGE tool is effective for improving family engagement in ICU care?
Research has shown that the NGAGE tool might help family members become more involved in patient care. An initial study found that 69% of family members used the tool, indicating its practicality for everyday use. In this trial, participants in the intervention group will receive access to the NGAGE tool, enabling families to share their care preferences with healthcare teams, potentially enhancing their involvement in care. Participants in the control group will not have access to the NGAGE tool and will engage in care according to current family engagement practices. While these results are encouraging, further testing is needed to confirm its effectiveness in various situations.12678
Who Is on the Research Team?
Michael J Goldfarb, MD, MSc
Principal Investigator
Lady Davis Institute, McGill University, Jewish General Hospital
Are You a Good Fit for This Trial?
This trial is for adult family members (age ≥ 18 years) of ICU patients expected to stay in the ICU for at least 48 hours. Participants must be able to engage in English or French. It's designed to see if a tool called NGAGE can help them get more involved in their loved one's care.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Control Phase
Participants receive usual care without access to the NGAGE tool
Intervention Phase
Participants in the intervention group are provided access to the NGAGE tool, which includes modules to Learn, Engage, and Report
Follow-up
Participants are monitored for family engagement, communication quality, satisfaction, and mental health outcomes
What Are the Treatments Tested in This Trial?
Interventions
- NGAGE tool
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lady Davis Institute
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator